Mepolizumab to CRSwNP Through 12 Months - Randomised to FESS and Non-FESS Within the First 2 Weeks
Clinical trial NCT05598814 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05598814
- Sponsor
- Vibeke Backer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2023-04-01
- Primary completion
- 2024-08-31
- Enrollment
- 58
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.